Treatment Intensity for the Management of Cardiogenic Shock
Shashank S. Sinha(Inova Fairfax Hospital), Navin K. Kapur(Tufts University), Maya Guglin(Indiana University Health), Claudius Mahr(University of Washington Medical Center), Van‐Khue Ton(Massachusetts General Hospital), Arvind Bhimaraj(Houston Methodist), Jeffrey A. Marbach(Tufts Medical Center), A.R. Garan(Beth Israel Deaconess Medical Center), Adnan Khalif(Allegheny Health Network), Rachna Kataria(Massachusetts General Hospital), Jaime Hernández-Montfort(Baylor Scott & White Health), Katherine Thayer(Tufts Medical Center), Daniel Burkhoff(Witten/Herdecke University), Song Li(University of Pittsburgh), Wissam Khalife(The University of Texas Medical Branch at Galveston), Andrew Schwartzman(Maine Medical Center), Mohit Pahuja, Manreet Kanwar(Allegheny Health Network), Esther Vorovich(Northwestern Medicine), Haroon Faraz(Hackensack Meridian Health), Paulina Baca(Tufts Medical Center), Jacob Abraham(Providence College), Detlef Wencker(Baylor Scott & White Health), Sandeep Nathan(University of Chicago), Saraschandra Vallabhajosyula, Ju H. Kim(Houston Methodist), Vanessa Blumer(Duke Medical Center), Anthony J. Faugno(Tufts Medical Center), Gavin Hickey(University of Pittsburgh Medical Center), Fatou Dieng(Tufts Medical Center), Neil Harwani(Tufts Medical Center), Yijing Zhang(Tongji University), Borui Li(Tufts Medical Center), Michael Yaoyao Yin(Tufts Medical Center), Shelley Hall
Cited by 17
Related Papers
The SGLT2 inhibitor dapagliflozin in heart failure with preserved ejection fraction: a multicenter randomized trial
|Nature Medicine|2021|599
Association Between Early Treatment With Tocilizumab and Mortality Among Critically Ill Patients With COVID-19
|JAMA Internal Medicine|2020|555
Criteria for Defining Stages of Cardiogenic Shock Severity
|Journal of the American College of Cardiology|2022|283
Extracorporeal cardiopulmonary resuscitation in adults: evidence and implications
|Intensive Care Medicine|2021|252